Aline Miyoko Sakaguchi Yamashita

Aline Miyoko Sakaguchi Yamashita

Auto-generated profile, based on publicly available information

Aline Miyoko Sakaguchi Yamashita

Lillehei Heart Institute, Department of Medicine, University of Minnesota, Minneapolis, MN 55455, USA

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2015 in Antioxidants & Redox Signaling
Verified
Journal Article
Closed access
CFCícero Figueiredo-Freitas
Cícero Figueiredo-Freitas
RDRaul Dulce
Raul Dulce
MFMatthew Foster
Matthew Foster
JLJingsheng Liang
Jingsheng Liang
AYAline M.S. Yamashita
Aline M.S. Yamashita
JPJose Renato Pinto
Jose Renato Pinto
Aims: The heart responds to physiological and pathophysiological stress factors by increasing its production of nitric oxide (NO), which reacts with intracellular glutathione to form S -nitrosoglutathione (GSNO), a protein S -nitrosylating agent. Although S -nitrosylation protects some cardiac proteins against oxidative stress, direct effects on myofilament performance are unknown. We hypothesize that S -nitrosylation of sarcomeric proteins will modulate the performance of cardiac myofilaments. Results: Incubation of intact mouse cardiomyocytes with S -nitrosocysteine (CysNO, a cell-permeable low-molecular-weight nitrosothiol) significantly decreased myofilament Ca 2+ sensitivity. In demembranated (skinned) fibers, S -nitrosylation with 1 μ M GSNO also decreased Ca 2+ sensitivity of contraction and 10 μ M reduced maximal isometric force, while inhibition of relaxation and myofibrillar ATPase required higher concentrations (≥100 μ M ). Reducing S -nitrosylation with ascorbate partially reversed the effects on Ca 2+ sensitivity and ATPase activity. In live cardiomyocytes treated with CysNO, resin-assisted capture of S -nitrosylated protein thiols was combined with label-free liquid chromatography–tandem mass spectrometry to quantify S -nitrosylation and determine the susceptible cysteine sites on myosin, actin, myosin-binding protein C, troponin C and I, tropomyosin, and titin. The ability of sarcomere proteins to form S -NO from 10–500 μ M CysNO in intact cardiomyocytes was further determined by immunoblot, with actin, myosin, myosin-binding protein C, and troponin C being the more susceptible sarcomeric proteins. Innovation and Conclusions: Thus, specific physiological effects are associated with S -nitrosylation of a limited number of cysteine residues in sarcomeric proteins, which also offer potential targets for interventions in pathophysiological situations. Antioxid. Redox Signal. 23, 1017–1034.

1 July 2017 in American Journal of Physiology-Cell Physiology
Verified
Journal Article
Closed access
PDF file
AYAline M. S. Yamashita
Aline M. S. Yamashita
MAMaryana T. C. Ancillotti
Maryana T. C. Ancillotti
LRLuciana Pereira Rangel
Luciana Pereira Rangel
MFMarcio Fontenele
Marcio Fontenele
CFCicero Figueiredo-Freitas
Cicero Figueiredo-Freitas
LNLeonardo Nogueira
Leonardo Nogueira
Nitric oxide (NO) contributes to myogenesis by regulating the transition between myoblast proliferation and fusion through cGMP signaling. NO can form S-nitrosothiols (RSNO), which control signaling pathways in many different cell types. However, neither the role of RSNO content nor its regulation by the denitrosylase activity of S-nitrosoglutathione reductase (GSNOR) during myogenesis is understood. Here, we used primary cultures of chick embryonic skeletal muscle cells to investigate whether changes in intracellular RSNO alter proliferation and fusion of myoblasts in the presence and absence of cGMP. Cultures were grown to fuse most of the myoblasts into myotubes, with and without S-nitrosocysteine (CysNO), 8-Br-cGMP, DETA-NO, or inhibitors for NO synthase (NOS), GSNOR, soluble guanylyl cyclase (sGC), or a combination of these, followed by analysis of GSNOR activity, protein expression, RSNO, cGMP, and cell morphology. Although the activity of GSNOR increased progressively over 72 h, inhibiting GSNOR (by GSNOR inhibitor – GSNORi – or by knocking down GSNOR with siRNA) produced an increase in RSNO and in the number of myoblasts and fibroblasts, accompanied by a decrease in myoblast fusion index. This was also detected with CysNO supplementation. Enhanced myoblast number was proportional to GSNOR inhibition. Effects of the GSNORi and GSNOR knockdown were blunted by NOS inhibition, suggesting their dependence on NO synthesis. Interestingly, GSNORi and GSNOR knockdown reversed the attenuated proliferation obtained with sGC inhibition in myoblasts, but not in fibroblasts. Hence myoblast proliferation is enhanced by increasing RSNO, and regulated by GSNOR activity, independently of cGMP production and signaling.

13 April 2023 in Cells
Verified
Journal Article
Open access
PDF file
JBJune Baik
June Baik
COCarolina Ortiz-Cordero
Carolina Ortiz-Cordero
AMAlessandro Magli
Alessandro Magli
KAKarim Azzag
Karim Azzag
SCSarah B. Crist
Sarah B. Crist
RPRita Perlingeiro
Rita Perlingeiro
Pluripotent stem (PS) cells enable the scalable production of tissue-specific derivatives with therapeutic potential for various clinical applications, including muscular dystrophies. Given the similarity to human counterparts, the non-human primate (NHP) is an ideal preclinical model to evaluate several questions, including delivery, biodistribution, and immune response. While the generation of human-induced PS (iPS)-cell-derived myogenic progenitors is well established, there have been no data for NHP counterparts, probably due to the lack of an efficient system to differentiate NHP iPS cells towards the skeletal muscle lineage. Here, we report the generation of three independent Macaca fascicularis iPS cell lines and their myogenic differentiation using PAX7 conditional expression. The whole-transcriptome analysis confirmed the successful sequential induction of mesoderm, paraxial mesoderm, and myogenic lineages. NHP myogenic progenitors efficiently gave rise to myotubes under appropriate in vitro differentiation conditions and engrafted in vivo into the TA muscles of NSG and FKRP-NSG mice. Lastly, we explored the preclinical potential of these NHP myogenic progenitors in a single wild-type NHP recipient, demonstrating engraftment and characterizing the interaction with the host immune response. These studies establish an NHP model system through which iPS-cell-derived myogenic progenitors can be studied.

29 December 2023 in Cells
Verified
Journal Article
Open access
PDF file
PAPhablo Abreu
Phablo Abreu
BGBayardo Isidore Garay
Bayardo Isidore Garay
TNTravis Nemkov
Travis Nemkov
AYAline M. S. Yamashita
Aline M. S. Yamashita
RPRita Perlingeiro
Rita Perlingeiro
In vitro-generated pluripotent stem cell (PSC)-derived Pax3-induced (iPax3) myogenic progenitors display an embryonic transcriptional signature, but upon engraftment, the profile of re-isolated iPax3 donor-derived satellite cells changes toward similarity with postnatal satellite cells, suggesting that engrafted PSC-derived myogenic cells remodel their transcriptional signature upon interaction within the adult muscle environment. Here, we show that engrafted myogenic progenitors also remodel their metabolic state. Assessment of oxygen consumption revealed that exposure to the adult muscle environment promotes overt changes in mitochondrial bioenergetics, as shown by the substantial suppression of energy requirements in re-isolated iPax3 donor-derived satellite cells compared to their in vitro-generated progenitors. Mass spectrometry-based metabolomic profiling further confirmed the relationship of engrafted iPax3 donor-derived cells to adult satellite cells. The fact that in vitro-generated myogenic progenitors remodel their bioenergetic signature upon in vivo exposure to the adult muscle environment may have important implications for therapeutic applications.

Verified
Journal Article
Open access
PDF file
KAKarim Azzag
Karim Azzag
HGHeather Marie Gransee
Heather Marie Gransee
AMAlessandro Magli
Alessandro Magli
AYAline M. S. Yamashita
Aline M. S. Yamashita
STSudheer Tungtur
Sudheer Tungtur
RPRita Perlingeiro
Rita Perlingeiro
The diaphragm muscle is essential for breathing, and its dysfunctions can be fatal. Many disorders affect the diaphragm, including muscular dystrophies. Despite the clinical relevance of targeting the diaphragm, there have been few studies evaluating diaphragm function following a given experimental treatment, with most of these involving anti-inflammatory drugs or gene therapy. Cell-based therapeutic approaches have shown success promoting muscle regeneration in several mouse models of muscular dystrophy, but these have focused mainly on limb muscles. Here we show that transplantation of as few as 5000 satellite cells directly into the diaphragm results in consistent and robust myofiber engraftment in dystrophin- and fukutin-related protein-mutant dystrophic mice. Transplanted cells also seed the stem cell reservoir, as shown by the presence of donor-derived satellite cells. Force measurements showed enhanced diaphragm strength in engrafted muscles. These findings demonstrate the feasibility of cell transplantation to target the diseased diaphragm and improve its contractility.

4 December 2021 in Research, Society and Development
Verified
Journal Article
Open access
PDF file
CCCarolina Pereira Coelho
Carolina Pereira Coelho
SGSávio Andrei Ricardo de Almeida Guedes
Sávio Andrei Ricardo de Almeida Guedes
AMAnastácia Mariana da Costa Melo
Anastácia Mariana da Costa Melo
COCyntia Ferreira de Oliveira
Cyntia Ferreira de Oliveira
AMAdriana Lau da Silva Martins
Adriana Lau da Silva Martins
AYAline Miyoko Sakaguchi Yamashita
Aline Miyoko Sakaguchi Yamashita
A dieta cetogênica é caracterizada por ser uma dieta rica em gordura, pobre em carboidratos e moderada em proteínas. A epilepsia é definida como um distúrbio neurológico crônico tendo como característica convulsões recorrentes e não provocadas e a epilepsia refratária acontece quando os medicamentos não reduzem as crises de forma significativa. O objetivo desse trabalho é avaliar a dieta cetogênica clássica no tratamento da epilepsia refratária em crianças e adolescentes. A metodologia usada baseia-se em uma revisão de literatura, onde a coleta de dados foi feita utilizando-se artigos, teses e sites. Os resultados encontrados indicam que a dieta cetogênica demonstra ser uma alternativa segura e eficaz. No entanto, existem efeitos colaterais e limitações relacionadas às resistências e dificuldades dos responsáveis que podem comprometer a eficácia do tratamento. Para o sucesso da dieta é importante que haja a cooperação dos familiares, o acompanhamento por uma equipe multidisciplinar durante todo o tratamento, e a atuação do nutricionista é de suma importância.